Literature DB >> 27190848

Analysis of Intraoperative and Postoperative Complications in Pseudoexfoliation Eyes Undergoing Cataract Surgery.

B C Hemalatha1, Sathyendranath B Shetty2.   

Abstract

INTRODUCTION: Pseudoexfoliation (PXE) is a genetically inherited condition affecting usually seen in those aged over 50 years. Surgical management of cataract in patients with PXE pose a challenge due to associated changes in ocular structures. AIM: To study the challenges in the management of cataract in patients with PXE.
MATERIALS AND METHODS: This was an interventional study conducted in the Ophthalmology Department of MS Ramaiah Medical College and Memorial Hospital, Bangalore from June 2012 to September 2014. All patients admitted for cataract surgery during this period who were diagnosed as cataract associated with PXE above 50 years of age belonging to either sex were included in the study. All patients underwent cataract surgery with intraocular lens implantation. Depending on type of cataract both small incision and phacoemulsification operations were conducted. Intraoperative and postoperative complications were studied. The patients were reviewed up to 6 weeks postoperatively.
RESULTS: A total of 50 eyes of 50 patients diagnosed as cataract with PXE underwent cataract surgery. Of which 40 eyes (80%) underwent small incision cataract surgery whereas, 10 (20%) underwent phacoemusification. Corneal thinning (<535 microns) was noted in majority of the cases (41 cases). Preoperatively there were 3 cases of zonular weakness. Pseudo exfoliation with glaucoma was seen in 5 cases. Intraoperative complications encountered during surgery were; zonular dialysis in 3 cases, posterior capsular tear in 2 cases, out of these 5 cases vitreous loss was seen in 3 cases. Postoperative complications were corneal odema in 17 cases, of which endothelium de-compensated in one case, while early posterior capsular opacification was seen in 6 cases. Final best corrected visual acuity was between 6/6-6/12 in 39(78%) eyes, 6/18 -6/36 in 6(12%) cases; 6/60 to less in 5(10%) cases.
CONCLUSION: Cataract surgery in eyes with PXE has higher incidence of intraoperative and postoperative complications. A complete preoperative workup helps reduce intraoperative complications and maximises the postoperative results. As corneal thinning is more common a pre-operative pachymetry is desirable to prevent underdiagnoses of glaucoma.

Entities:  

Keywords:  Glaucoma; Pachymetry; Phacoemulsification; Posterior capsular rent

Year:  2016        PMID: 27190848      PMCID: PMC4866146          DOI: 10.7860/JCDR/2016/17548.7545

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  24 in total

1.  Anterior capsule contraction and intraocular lens dislocation in eyes with pseudoexfoliation syndrome.

Authors:  H Hayashi; K Hayashi; F Nakao; F Hayashi
Journal:  Br J Ophthalmol       Date:  1998-12       Impact factor: 4.638

2.  Pseudoexfoliation syndrome and secondary cataract.

Authors:  M Küchle; A Amberg; P Martus; N X Nguyen; G O Naumann
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

3.  Pupillary dilation in eyes with pseudoexfoliation syndrome.

Authors:  E F Carpel
Journal:  Am J Ophthalmol       Date:  1988-06-15       Impact factor: 5.258

4.  Intraoperative and Immediate Postoperative Outcomes of Cataract Surgery using Phacoemulsification in Eyes with and without Pseudoexfoliation Syndrome.

Authors:  Neelam R Dwivedi; Arun K Dubey; P Ravi Shankar
Journal:  J Clin Diagn Res       Date:  2014-12-05

5.  Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome.

Authors:  B W Streeten; Z Y Li; R N Wallace; R C Eagle; A A Keshgegian
Journal:  Arch Ophthalmol       Date:  1992-12

6.  Pseudoexfoliation in South India.

Authors:  H Arvind; P Raju; P G Paul; M Baskaran; S Ve Ramesh; R J George; C McCarty; L Vijaya
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 7.  Pseudoexfoliation and the cataract surgeon: preoperative, intraoperative, and postoperative issues related to intraocular pressure, cataract, and intraocular lenses.

Authors:  Bradford J Shingleton; Alan S Crandall; Iqbal Ike K Ahmed
Journal:  J Cataract Refract Surg       Date:  2009-06       Impact factor: 3.351

8.  Pseudoexfoliation syndrome: a cohort study on intraoperative complications in cataract surgery.

Authors:  L Scorolli; L Scorolli; E C Campos; L Bassein; R A Meduri
Journal:  Ophthalmologica       Date:  1998       Impact factor: 3.250

9.  The prevalence of pseudoexfoliation syndrome in Pakistan. Hospital based study.

Authors:  Rashad Qamar Rao; Tariq Mehmood Arain; Muhammad Ali Ahad
Journal:  BMC Ophthalmol       Date:  2006-06-22       Impact factor: 2.209

10.  Central corneal thickness in subjects with glaucoma and in normal individuals (with or without pseudoexfoliation syndrome).

Authors:  Georgios Kitsos; Christos Gartzios; Ioannis Asproudis; Eleni Bagli
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more
  4 in total

1.  Manual small incision cataract surgery: a viable option for cataract with pseudoexfoliation.

Authors:  Sruthi Rajendran; A R Rajalakshmi; K Srikanth; G Ezhumalai
Journal:  Int Ophthalmol       Date:  2021-11-28       Impact factor: 2.031

2.  Frequency and surgical difficulties associated with pseudoexfoliation syndrome among Indian rural population scheduled for cataract surgery: Hospital-based data.

Authors:  Rajesh S Joshi; Sonali V Singanwad
Journal:  Indian J Ophthalmol       Date:  2019-02       Impact factor: 1.848

3.  Surgical experience with a redesigned, fully preloaded, hydrophobic acrylic intraocular lens in challenging cases of pseudoexfoliation syndrome, phacodonesis, and small pupils.

Authors:  Andreas F Borkenstein; Eva-Maria Borkenstein
Journal:  Clin Ophthalmol       Date:  2019-01-22

4.  Intraoperative and postoperative complications of cataract surgery in eyes with pseudoexfoliation - An 8-year analysis.

Authors:  Thanigasalam Thevi; Adinegara Lutfi Abas
Journal:  Oman J Ophthalmol       Date:  2019-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.